HR 1780 · 118th Congress 2023–2025, ended

Finn Sawyer Access to Cancer Testing Act

Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 24, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Cosponsors 18

Members who signed on, in the order they did. Signatures ran from Mar 24, 2023 to Dec 22, 2023; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-CADoris O. MatsuiOriginalMar 24, 2023
D-MDGlenn IveyApr 6, 2023
D-NJJefferson Van DrewApr 6, 2023
D-AZRaúl M. GrijalvaApr 6, 2023
D-FLDebbie Wasserman SchultzMay 25, 2023
R-NEDon BaconMay 25, 2023
R-TXPete SessionsMay 25, 2023
R-NYClaudia TenneyJun 14, 2023
D-CTJames A. HimesJun 14, 2023
D-ALTerri A. SewellJun 14, 2023
D-PAChristopher R. DeluzioJun 16, 2023
R-KYAndy BarrJun 23, 2023
D-MEChellie PingreeJun 30, 2023
D-NJJosh GottheimerAug 11, 2023
D-NVDina TitusSep 21, 2023
D-COJason CrowSep 21, 2023
D-COJoe NeguseSep 21, 2023
D-NHChris PappasDec 22, 2023

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 24, 2023
Health Subcommittee
Referred Mar 31, 2023
HouseWays and Means Committee
Referred Mar 24, 2023
Health Subcommittee
Referred Dec 17, 2024

Actions 4

Everything that happened, newest first.

  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Mar 31, 2023Referred to the Subcommittee on Health.
  3. Mar 24, 2023Introduced in House
  4. Mar 24, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: This bill is enacted pursuant to Article 1, Section 8, Clause 18 of the Constitution of the United States. The single subject of this legislation is: This bill provides coverage under Medicare, Medicaid, and CHIP to full molecular diagnostics and DNA sequencing at the time of cancer diagnosis.

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 54, March 24, 2023, page H1438.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 642Finn Sawyer Access to Cancer Testing ActRelated billMar 2, 2023

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To facilitate the development of treatments for cancer, and for other purposes.
Short Title(s) as Introduced
Finn Sawyer Access to Cancer Testing Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 24, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.